Develops cancer and vaccine drugs.
Jun 2026Revenue $66.6B/yrExpenses $60.6B/yr
No trend
Figures by year
Is Merck & profitable?
Yes. In the 12 months to Jun 2026, revenue was $66.6B and expenses $60.6B.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $65.0B | $43.9B | $21.1B |
| Dec 2024 | $64.2B | $44.2B | $19.9B |
| Dec 2023 | $60.1B | $58.2B | $1.89B |
| Dec 2022 | $59.3B | $42.8B | $16.4B |
| Dec 2021 | $48.7B | $34.8B | $13.9B |
| Dec 2020 | $41.5B | $35.7B | $5.86B |
| Dec 2019 | $39.1B | $31.9B | $7.17B |
| Dec 2018 | $42.3B | $33.6B | $8.70B |
| Dec 2017 | $40.1B | $33.6B | $6.52B |
| Dec 2016 | $39.8B | $35.1B | $4.66B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.